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This paper reports the findings of a priority setting process, undertaken with cancer and palliative care 
clinicians, to better understand the characteristics of medication errors with opioids within their services. 
Participants representing six public hospitals in one Australian state, took part in a series of priority setting 
workshops, and, drawing on actual incidents occurring in their services, sought to identify where in the opioid 
medication process errors were most frequently occurring. Opioid error types and perceived contributing factors 
were explored, and strategies to reduce/prevent opioid errors were proposed. The priority setting process 
provided valuable insights into the types of opioid errors that occur in cancer and palliative care services, and 
the complexity of addressing opioid errors from the clinician's perspective. The findings from this priority 
setting process will inform future targeted quality improvement initiatives to support safe opioid medication 
practices in cancer and palliative care services.  
Background 
Opioids are a high-risk medicine [1], widely used in cancer and palliative care services as the primary 
pharmacological treatment for cancer pain [2-4]. Adult cancer and palliative care patients are at increased risk of 
medication errors and resultant harm due to their age [5], co-morbidities which may alter medication 
pharmacodynamics [6,7], and polypharmacy [8,9]. However, little is known about the incidence and 
characteristics of opioid errors in cancer and palliative care services [10].  
Context: As part of a larger study [11], cancer and palliative care clinicians (‘clinicians’) from one Australian 
cancer research network (‘CRN’) identified opioid errors as a quality improvement priority. Clinicians were 
subsequently invited to attend a series of priority setting workshops (‘workshop’) to explore the scope of opioid 
errors within their services [12]. This process was undertaken as part of the planning phase for a future quality 
improvement project across the network. 
Aim: The aim of the priority setting process was to explore the perceived scope and contributing factors to 
opioid errors, in the context of the cancer and palliative care clinical setting. 
Methods: Two workshops were conducted at two hospital sites on separate days, each running for 
approximately two hours. Workshops were attended by nine clinicians from both inpatient and community 
services (medical oncologists (n=2); oncology clinical nurse educator (n=1); palliative care consultant (n=1); 
palliative care nurse unit manager (n=1); palliative care clinical nurse consultants (n=2); pharmacists (n=2), 
hospital and community). Workshops were facilitated by an independent clinical academic (JLP), nominated 
and funded through a larger CRN project [11]. 
Clinicians were asked to consider the following questions in the context of the cancer and palliative care clinical 
setting: i) Why are opioid errors problematic? ii) What are the perceived characteristics and frequency of opioid 
errors?; iii) What are the perceived opioid error contributing factors?; and v) What are the opportunities to 
reduce opioid errors in the clinical setting? 
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Key discussion points were captured and recorded onto flipcharts by a scribe (NH, CA) throughout each 
workshop. At the conclusion of each workshop, discussion points were transcribed verbatim into a word 
document. The transcribed discussion points were circulated to respective workshop participants for comments 
and consensus prior to thematic analysis[13] being undertaken by three authors (NH, JP, CA). 
Clinicians’ perceptions 
As a starting point, clinicians reflected on recent opioid errors in their services. Clinicians perceived opioid 
errors were a regular occurrence but this was not always reflected in incident reports, primarily because some 
were perceived to be ‘safe errors’, such as errors that did not reach the patient. Clinicians acknowledged that 
opioid errors that resulted in patient harm in all services were due to both opioid overdose and under-dose.   
Opioid error types 
Transcription, conversion, prescribing and administration errors, were the primary opioid error types identified 
by clinicians as being problematic (Table 1). Transcription errors were most prominent when patients were 
admitted to the inpatient service from the community. Patients’ unable to accurately recall their medications, 
underpinned by a lack of robust assessment on admission, were the main perceived contributors to transcription 
errors. 
Opioid conversion errors, particularly when converting between different routes of administration, or between 
long acting and short acting opioids, were considered the most prevalent error type. While each service provided 
opioid conversion charts, and all clinicians had access to an online opioid calculator [14], clinicians questioned 
how confident medical and nursing professionals were using these tools, and whether the conversion charts were 
always adequate given the complexity of effective opioid dosing in cancer pain.    
Prescribing errors were perceived to result from: failing to recognise existing or previous opioid use; not 
considering the impact of co-morbidities on opioid metabolism, (e.g., renal/hepatic disease); and lack of 
knowledge of opioid dosing principles.  
Wrong drug and wrong route errors were the predominant administration errors identified. Clinicians stressed 
the importance of staying up to date with the continually increasing opioid formulations available, and 
recognising the potential for error with similar sounding drug names, such as Oxycontin/MS Contin. Unclear 
opioid orders were considered a key factor leading to wrong route errors, as was failing to double check the 
opioid order prior to administration. 
Human factors 
Clinicians acknowledged the classification of opioids as high risk medicines and the additional steps required to 
ensure patient safety throughout the opioid medication process. Human factors, such as interruptions during the 
opioid administration process were perceived as a major contributing factor to opioid error. Gaps in clinicians’  
opioid delivery knowledge and skills, and the assumption that clinicians are confident with core clinical skills, 
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such as undertaking basic opioid calculations/conversions, and titration, were seen as contributing factors to all 
opioid error types.  
Proposed strategies 
Having identified perceived factors contributing to opioid errors, clinicians proposed three priority areas for 
future quality improvement initiatives: i) targeting commonly occurring opioid error types; ii) reducing human 
error; and iii) identifying and addressing gaps in clinicians’ knowledge and skills (Table 1).  
Multiple strategies to reduce opioid error were proposed (Table 1), including: using standardised tools for 
opioid calculations/conversions; promoting clinician adherence to medication management policy; identifying 
gaps in skills and knowledge; and supporting clinicians to strengthen opioid delivery competencies. However, 
development of implementation strategies was beyond the scope of the workshops. 
[Insert Table 1] 
Table 1: Clinicians’ perceptions of priority quality improvement areas pertaining to safe opioid delivery 
in cancer and palliative care services  
Implications for future research 
This priority setting exercise highlighted the need for further exploration of opioid errors in cancer and palliative 
care services, at both a state-wide and local level. Undertaking a jurisdictional level review of clinical incident 
reports involving opioids in cancer and palliative care services will provide additional insights into opioid error 
incidence, characteristics, patient impact, and potential contributing factors. In-depth exploration of cancer and 
palliative care clinicians’ perceptions of barriers and facilitators to safe opioid delivery, from both an individual 
and systems perspective, is also essential to better understanding the burden and context of opioid errors in this 
clinical setting. These data will guide the development of tailored strategies to support safe opioid delivery in 
cancer and palliative care services. 
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Table 1: Clinicians’ perceptions of priority quality improvement areas pertaining to safe opioid delivery 
in cancer and palliative care services  
Priority area Perceived causes/contributing factors Proposed strategies to reduce error 
1. Addressing key  opioid error types 
Transcription errors  high risk of error on admission from 
community to inpatient service 
 opioids not documented on admission 
 patient can’t articulate (“I take the blue 
one”) 
 ‘as required/PRN’ opioids not included 
 no full assessment on admission 
 
 comprehensive assessment and accurate 
documentation on admission 
 routinely confirm opioid and dose 
 awareness of and ready access to resources 
to identify current/previous opioid 
(pharmacist) 
 encourage family to bring opioids to unit 
where possible 
Opioid conversion errors  difficulty with calculations e.g., volume vs 
mg, decimal points 
 clinicians not confident checking/doing 
calculations 
 unclear requirements/policy around 
checking calculations 
 polypharmacy compounds error risk 
 human error e.g., interruptions 
 team culture/interactions – punitive  vs. 
collegial  
 not utilising evidence 
 steep learning curve for junior clinicians 
 using standardised tools to 
calculate/convert opioids 
 awareness and application of conversion 
policy  
 building knowledge to access and apply 
relevant resources, e.g. opioid conversion 
charts 
 being confident/comfortable checking 
calculations and conversions 
 making checking routine for every dose 
 identifying wrong conversions and taking 
action 
 
Prescribing errors  lack of knowledge of opioid dosing 
principles 
 not recognising previous/existing opioid 
usage  
 lack of awareness of metabolic processes 
 attitudinal - side effects not important if 
patient comfortable; conversely, pain not 
seen as an issue 
 opioid altered without appropriate 
consultation  
 robust patient history and pain assessment 
 rule out underlying physiological 
conditions  
 recognising previous/existing opioid usage  
 consequences of inappropriate alteration of 
opioid  
 under-prescribing as harmful to patient as 
over-prescribing 
 recognising opioid toxicity 
 seek specialist advice, e.g., methadone 
prescribing 
Administration errors - 
wrong drug 
 similar sounding drug names, e.g., 
Oxycontin/MS Contin;  
morphine/hydromorphone  
 using trade names vs generic when 
charting opioids, e.g., Endone/Oxynorm 
vs. oxycodone 
 recognise potential for errors with similar 
sounding drug names 
 awareness and application of local policies 
re drug checking 
Administration errors - 
wrong route 
 incomplete/unclear prescription e.g., ‘per 
oral/subcut’ 
 not checking order e.g., per oral ordered 
but given subcutaneously  
 transdermal patch not routinely checked/ 
removed  
 awareness and application of local policies 
re drug administration  
 routine checking and ongoing pain 
assessment with transdermal patch 
 
2. Reducing human 
error 
 interruptions 
 additional time required for opioid 
administration  - independent double 
check, patient assessment 
 not routinely checking every dose 
 awareness and application of local policies 
re opioid delivery 
 supporting vigilance in delivery of opioids 
(high risk medicine) 
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Priority area Perceived causes/contributing factors Proposed strategies to reduce error 
 shortcuts/workarounds to reduce time 
3. Clinician knowledge 
and skills 
 assumption clinicians (junior and senior) 
are confident with core clinical skills 
 steep learning curve for junior clinicians or 
clinicians new to palliative care  
 clinicians’ pharmacology knowledge often 
lacking 
 
 opportunities to identify knowledge and 
skill gaps  
 reduce the stigma of ‘not knowing’ by 
offering education options that can be 
undertaken individually vs. in a group 
Participating clinicians (n=9): Medical oncology consultants (n=2), palliative care consultant (n=1), palliative 
care nurse unit manager (n=1), oncology clinical nurse educator (n=1), palliative care clinical nurse 
consultants (n=2), pharmacists (n=2). 
 
 
